The effect of leptin administration on mammary tumor growth in diabetic mice

Hormone and Metabolic Research

Volumn 45, Issue 9, 2013, Pages 655-659

  Bitton Worms, K ^a   Rostoker, R ^a   Braun, S ^a   Shen Orr, Z ^a   Leroith, D ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

cancer; leptin; metabolism

Indexed keywords

LEPTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; ONCOGENE; OSMOTIC PUMP; PRIORITY JOURNAL;

MUS;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; LEPTIN; MALE; MAMMARY NEOPLASMS, ANIMAL; MICE;

EID: 84882886015     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1345151     Document Type: Article

References (35)

1. Loi S., Milne R. L., Friedlander M. L., McCredie MR E., Giles G. G., Hopper J. L., Phillips K. A. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev: 2005; 14 1686 1691 (Pubitemid 40995080)
2. Porter G. A., Inglis K. M., Wood L. A., Veugelers P. J. Effect of obesity on presentation of breast cancer. Ann Surg Oncol: 2006; 13 327 332 (Pubitemid 43255915)
3. Harvie M., Hooper L., Howell A. Central obesity and breast cancer risk: a systematic review. Obesity Rev: 2003; 4 157 173 (Pubitemid 36950578)
4. Dawood S., Broglio K., Gonzalez-Angulo A. M., Kau S. W., Islam R., Hortobagyi G. N., Cristofanilli M. Prognostic value of body mass index in locally advanced breast cancer. Clin Cancer Res: 2008; 14 1718 1725 (Pubitemid 351469456)
5. Daling J. R., Malone K. E., Doody D. R., Johnson L. G., Gralow J. R., Porter P. L. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer: 2001; 92 720 729 (Pubitemid 32783055)
6. Agnoli C., Berrino F., Abagnato C. A., Muti P., Panico S., Crosignani P., Krogh V. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case-control study. Nutr Metab Cardiovasc Dis: 2010; 20 41 48
7. Pasanisi P., Berrino F., De Petris M., Venturelli E., Mastroianni A., Panico S. Metabolic syndrome as a prognostic factor for breast cancer recurrences. Inter J Cancer: 2006; 119 236 238
8. Goodwin P. J., Ennis M., Pritchard K. I., Trudeau M. E., Koo J., Taylor S. K., Hood N. Insulin-and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol: 2012; 30 164 171
9. De Stefani E., Mendilaharsu M., Deneo-Pellegrini H., Ronco A. Influence of dietary levels of fat, cholesterol, and calcium on colorectal cancer. Nutr Cancer: 1997; 29 83 89 (Pubitemid 27508129)
10. Platz E. A., Clinton S. K., Giovannucci E. Association between plasma cholesterol and prostate cancer in the PSA era. Inter J Cancer: 2008; 123 1693 1698
11. Zielinski C., Stuller I., Rausch P., Müller C. Increased serum concentrations of cholesterol and triglycerides in the progression of breast cancer. J Cancer Res Clin Oncol: 1988; 114 514 518
12. Calle E. E., Thun M. J. Obesity and cancer. Oncogene: 2004; 23 6365 6378 (Pubitemid 39265505)
13. Yin N., Wang D., Zhang H., Yi X., Sun X., Shi B., Wu H., Wu G., Wang X., Shang Y. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res: 2004; 64 5870 5875 (Pubitemid 39095588)
14. Okumura M., Yamamoto M., Sakuma H., Kojima T., Maruyama T., Jamali M., Cooper D. R., Yasuda K. Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-α and PPAR expression. Biochim Biophys Acta (BBA) Molecul Cell Res: 2002; 1592 107 116
15. Mitrunen K., Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res: 2003; 544 9 41 (Pubitemid 36903202)
16. Hausman G., Richardson R. Adipose tissue angiogenesis. J Anim Sci: 2004; 82 925 934 (Pubitemid 38572359)
17. Folkman J. Angiogenesis and apoptosis. In: Seminars Cancer Biol. 2003; Elsevier 159 167
18. Liang Y., Brekken R. A., Hyder S. M. Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones. Endocr Rel Cancer: 2006; 13 905 919 (Pubitemid 44763266)
19. Sharma D., Wang J., Fu P. P., Sharma S., Nagalingam A., Mells J., Handy J., Page A. J., Cohen C., Anania F. A. Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology: 2010; 52 1713 1722
20. Toyoshima Y., Gavrilova O., Yakar S., Jou W., Pack S., Asghar Z., Wheeler M. B., LeRoith D. Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology: 2005; 146 4024 4035 (Pubitemid 41175774)
21. Ferguson R. D., Novosyadlyy R., Fierz Y., Alikhani N., Sun H., Yakar S., LeRoith D. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes. Breast Cancer Res: 2012; 14 R8
22. Fernández A. M., Kim J. K., Yakar S., Dupont J., Hernandez-Sanchez C., Castle A. L., Filmore J., Shulman G. I., Le Roith D. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Genes Develop: 2001; 15 1926 1934 (Pubitemid 32738622)
23. Carroll P. A., Healy L., Lysaght J., Boyle T., Reynolds J. V., Kennedy M. J., Pidgeon G., Connolly E. M. Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer. Mol Carcinogen: 2011; 50 643 651
24. Vona-Davis L., Rose D. P. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Rel Cancer: 2007; 14 189 206 (Pubitemid 47242622)
25. Somasundar P., Yu A. K., Vona-Davis L., McFadden D. W. Differential effects of leptin on cancer in vitro. J Surg Res: 2003; 113 50 55 (Pubitemid 36999792)
26. Frankenberry K. A., Skinner H., Somasundar P., McFadden D. W., Vona-Davis L. C. Leptin receptor expression and cell signaling in breast cancer. Inter J Oncol: 2006; 28 985 993
27. Hsieh F. C., Cheng G., Lin J. Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem Biophys Res Commun: 2005; 335 292 299 (Pubitemid 41140220)
28. Patel A. C., Nunez N. P., Perkins S. N., Barrett J. C., Hursting S. D. Effects of energy balance on cancer in genetically altered mice. J Nutr: 2004; 134 3394S 3398S (Pubitemid 39587580)
29. Li X., Wu X., Camacho R., Schwartz G. J., LeRoith D. Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms. PLoS One: 2011; 6 e17058
30. Martignoni M. E., Kunze P., Friess H. Cancer cachexia. Mol Cancer: 2003; 2 36
31. Kotler D. P. Cachexia. Ann Inter Med: 2000; 133 622 634
32. Bayliss T. J., Smith J. T., Schuster M., Dragnev K. H., Rigas J. R. A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer. Exp Opin Biol Ther: 2011; 11 1663 1668
33. Han L., Ma Q., Li J., Liu H., Li W., Ma G., Xu Q., Zhou S., Wu E. High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS One: 2011; 6 e27074
34. Liu H., Ma Q., Li J. High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells. Mol Cell Biochem: 2011; 347 95 101
35. Vander Heiden M. G., Locasale J. W., Swanson K. D., Sharfi H., Heffron G. J., Amador-Noguez D., Christofk H. R., Wagner G., Rabinowitz J. D., Asara J. M. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Sci Signal: 2010; 329 1492 1499